NCT04132622 (LDETPI) is a Phase 4 clinical trial of Levothyroxine Sodium in Paraquat Poisoning, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University.

Who is sponsoring NCT04132622?

NCT04132622 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University.

What drugs are being tested in NCT04132622?

Interventions in NCT04132622: Levothyroxine Sodium, Traditional therapy.

What condition does NCT04132622 study?

NCT04132622 studies Paraquat Poisoning.

Is NCT04132622 still recruiting?

NCT04132622 is currently status unknown. Last updated 22 October 2019.

Last reviewed 2019-10-22 · How we verify

NCT04132622: LDETPI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Low Dose Euthyrox in Treatments of Paraquat Intoxication.

Status unknown Phase 4 Last updated 22 October 2019

What this trial tests

Phase 4 trial testing Levothyroxine Sodium in Paraquat Poisoning in 80 participants. Status unknown.

Timeline

1 January 2020

Primary endpoint
31 December 2022

31 December 2023

Quick facts

Lead sponsor	Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	80
Start date	1 January 2020
Primary completion	31 December 2022
Estimated completion	31 December 2023

Drugs / interventions tested

Levothyroxine Sodium (LEVOTHYROXINE SODIUM) — full drug profile →
Traditional therapy — full drug profile →

Conditions studied

Paraquat Poisoning — all drugs for Paraquat Poisoning →

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Who can join

Eligibility, any sex, with Paraquat Poisoning. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Paraquat is a common human toxicant and accounts for 20 deaths per million persons in the world. Paraquat usually cause multiple organ dysfunction syndrome, including liver, kidney, lung and heart dysfunction. Besides, pituitary insufficiency also occurs on those patients with paraquat poisoning, which leads to multiple endocrine gland dysfunction, involving adrenal gland, thyroid and sex gland. As a result, the investigators decide to initiate the clinical trial to find whether thyroid replacement therapy can furtherly reduce the mortality, and improve patients long-term prognosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Levothyroxine Sodium

Trials testing the same drug.

NCT06073665 — Dosing of LT4 in Older Individuals · Phase 4 · recruiting
NCT05228184 — Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH) · Phase 4 · terminated
NCT04878614 — Comparison of Levothyroxine Formulation in Hypothyroid Patients With Enteral Feeding · Phase 4 · terminated
NCT03977207 — A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients · NA · recruiting
NCT03880578 — Quality of Life After Interventional Thyroid Treatment · completed

Other Second Affiliated Hospital, School of Medicine, Zhejiang University trials

Trials by the same sponsor.

NCT07445152 — Research on Construction and Verification of Multimodal Medical Imaging Large Model · not yet recruiting
NCT06775665 — A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population · not yet recruiting
NCT07533422 — Rescue Reatment of Helicobacter Pylori Based on Fecal Antimicrobial Resistance Gene Testing · NA · not yet recruiting
NCT07487285 — A Non-inferiority Study of Laser Combined With Ultrasonic Debridement Therapy (LCUDT) Versus Manual Combined With Ultras · NA · not yet recruiting
NCT07505186 — Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04132622 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Second Affiliated Hospital, School of Medicine, Zhejiang University
Last refreshed: 22 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04132622.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing